[Assessment of decision-making capacity in primary and secondary progressive multiple sclerosis]

A García-Molina1, A Enseñat-Cantallops, R Sánchez-Carrión

  • 1Institut Universitari de Neurorrehabilitació Guttmann, Universitat Autònoma de Barcelona, Badalona, Barcelona. agarciam.investigacio@guttmann.com

Abstract

Insights

Patients with multiple sclerosis (MS) show impaired decision-making, particularly those with primary progressive MS (PPMS). This difficulty in learning reward contingencies impacts daily life and autonomy.

Area of Science:

  • Neuroscience
  • Cognitive Psychology

Context:

  • Multiple Sclerosis (MS) is a neurodegenerative disease affecting cognitive functions.
  • Impaired decision-making significantly impacts daily living activities and patient autonomy in individuals with MS.

Purpose:

  • To assess decision-making capacity in patients with primary progressive MS (PPMS) and secondary progressive MS (SPMS).
  • To compare the decision-making performance of MS subtypes against healthy controls.

Summary:

  • The study utilized the Iowa Gambling Task (IGT) to evaluate decision-making in 19 MS patients (9 PPMS, 10 SPMS) and 18 healthy controls.
  • PPMS patients demonstrated poorer performance on the IGT compared to controls and SPMS patients.
  • SPMS patients exhibited decision-making abnormalities similar to PPMS, though not statistically significant compared to controls.

Impact:

  • Findings suggest decision-making impairments in MS are linked to difficulties in acquiring stimulus-reward contingencies.
  • Understanding these cognitive deficits is crucial for developing targeted interventions to improve quality of life for MS patients.